Immediate Impact
8 standout
Citing Papers
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products
2022 Standout
Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines
2019 Standout
Works of V. Estrade being referenced
CYSTECTOMY FOR SEVERE HEMORRHAGIC CYSTITIS IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS1
2000
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| V. Estrade | 212 | 101 | 68 | 40 | 299 | |
| Kazuro Kikkawa | 194 | 87 | 79 | 46 | 292 | |
| Francis A. Jefferson | 154 | 102 | 75 | 30 | 268 | |
| Francis Dubosq | 208 | 115 | 100 | 30 | 322 | |
| Mehmet Remzi Erdem | 171 | 139 | 115 | 31 | 335 | |
| Jianxing Li | 185 | 151 | 33 | 56 | 322 | |
| Philip Dundee | 129 | 34 | 97 | 32 | 229 | |
| Brian Blew | 225 | 105 | 74 | 25 | 288 | |
| Peter Aslan | 210 | 114 | 80 | 25 | 330 | |
| H. Gimbernat | 190 | 57 | 118 | 32 | 319 | |
| Peder Gjengstø | 252 | 158 | 67 | 24 | 317 |
All Works
Login with ORCID to disown or claim papers
Loading papers...